Yale University
New Haven, Connecticut, United States
Purpose
to develop an antigen delivery machine based on the type III protein delivery system that will not require the use of live-attenuated bacteria, offering a safer vaccine platform.
Division
Global Health
Date
October 2008
Region Served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
18
Grantee location
New Haven, Connecticut, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.